Work

Randomized, open-label phase II study of motesanib or bevacizumab in combination with paclitaxel and carboplatin (P/C) for advanced nonsquamous non-small cell lung cancer (NSCLC).

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.7528

Authors: G. R. Blumenschein, F. F. Kabbinavar, H. Menon, T. Mok, J. Stephenson, J. T. Beck, K. Lakshmaiah, K. Kracht, R. S. Sikorski, L. S. Schwartzberg

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2223123737

Cites:

Cited by: 16

Related to: 10